-DOCSTART- -X- O
This -X- _ O
review -X- _ O
highlights -X- _ O
the -X- _ O
growing -X- _ O
importance -X- _ O
of -X- _ O
protein -X- _ B-Intervention
epitope -X- _ I-Intervention
mimetics -X- _ I-Intervention
in -X- _ O
the -X- _ O
discovery -X- _ O
of -X- _ O
new -X- _ O
biologically -X- _ O
active -X- _ O
molecules -X- _ O
and -X- _ O
their -X- _ O
potential -X- _ O
applications -X- _ O
in -X- _ O
drug -X- _ O
and -X- _ O
vaccine -X- _ O
research. -X- _ O
The -X- _ O
focus -X- _ O
is -X- _ O
on -X- _ O
folded -X- _ O
β-hairpin -X- _ O
mimetics -X- _ O
, -X- _ O
which -X- _ O
are -X- _ O
designed -X- _ O
to -X- _ O
mimic -X- _ O
β-hairpin -X- _ O
motifs -X- _ O
in -X- _ O
biologically -X- _ O
important -X- _ O
peptides -X- _ O
and -X- _ O
proteins. -X- _ O
An -X- _ O
ever-growing -X- _ O
number -X- _ O
of -X- _ O
protein -X- _ B-Patient
crystal -X- _ I-Patient
structures -X- _ I-Patient
reveal -X- _ O
how -X- _ O
β-hairpin -X- _ O
motifs -X- _ O
often -X- _ O
play -X- _ O
key -X- _ O
roles -X- _ O
in -X- _ O
protein–protein -X- _ B-Patient
and -X- _ I-Patient
protein–nucleic -X- _ I-Patient
acid -X- _ I-Patient
interactions. -X- _ I-Patient
This -X- _ O
review -X- _ O
illustrates -X- _ O
how -X- _ O
using -X- _ O
protein -X- _ O
structures -X- _ O
as -X- _ O
a -X- _ O
starting -X- _ O
point -X- _ O
for -X- _ O
small-molecule -X- _ B-Intervention
mimetic -X- _ I-Intervention
design -X- _ I-Intervention
can -X- _ O
provide -X- _ O
novel -X- _ O
ligands -X- _ O
as -X- _ O
protein–protein -X- _ B-Intervention
interaction -X- _ I-Intervention
inhibitors -X- _ I-Intervention
, -X- _ O
as -X- _ O
protease -X- _ B-Intervention
inhibitors -X- _ I-Intervention
, -X- _ O
and -X- _ O
as -X- _ O
ligands -X- _ O
for -X- _ O
chemokine -X- _ B-Intervention
receptors -X- _ I-Intervention
and -X- _ O
folded -X- _ B-Intervention
RNA -X- _ I-Intervention
targets -X- _ I-Intervention
, -X- _ O
as -X- _ O
well -X- _ O
as -X- _ O
novel -X- _ O
antibiotics -X- _ B-Intervention
to -X- _ I-Intervention
combat -X- _ I-Intervention
the -X- _ I-Intervention
growing -X- _ I-Intervention
health -X- _ I-Intervention
threat -X- _ I-Intervention
posed -X- _ I-Intervention
by -X- _ I-Intervention
the -X- _ I-Intervention
emergence -X- _ I-Intervention
of -X- _ I-Intervention
antibiotic-resistant -X- _ I-Intervention
bacteria. -X- _ I-Intervention
The -X- _ O
β-hairpin -X- _ O
antibiotics -X- _ O
are -X- _ O
shown -X- _ O
to -X- _ O
target -X- _ O
a -X- _ O
β-barrel -X- _ O
outer -X- _ O
membrane -X- _ O
protein -X- _ O
( -X- _ O
LptD -X- _ O
) -X- _ O
in -X- _ O
Pseudomonas -X- _ O
sp. -X- _ O
, -X- _ O
which -X- _ O
is -X- _ O
essential -X- _ O
for -X- _ O
the -X- _ O
biogenesis -X- _ O
of -X- _ O
the -X- _ O
outer -X- _ O
cell -X- _ O
membrane. -X- _ O
Another -X- _ O
exciting -X- _ O
prospect -X- _ O
is -X- _ O
that -X- _ O
protein -X- _ B-Comparison
epitope -X- _ I-Comparison
mimetics -X- _ I-Comparison
will -X- _ I-Comparison
be -X- _ I-Comparison
of -X- _ I-Comparison
increasing -X- _ I-Comparison
importance -X- _ I-Comparison
in -X- _ I-Comparison
synthetic -X- _ I-Comparison
vaccine -X- _ I-Comparison
design -X- _ I-Comparison
, -X- _ I-Comparison
in -X- _ I-Comparison
the -X- _ I-Comparison
emerging -X- _ I-Comparison
field -X- _ I-Comparison
of -X- _ I-Comparison
structural -X- _ I-Comparison
vaccinology. -X- _ I-Comparison
Crystal -X- _ O
structures -X- _ O
of -X- _ O
protective -X- _ B-Intervention
antibodies -X- _ I-Intervention
bound -X- _ O
to -X- _ O
their -X- _ O
pathogen-derived -X- _ O
epitopes -X- _ O
provide -X- _ O
an -X- _ O
ideal -X- _ O
starting -X- _ O
point -X- _ O
for -X- _ O
the -X- _ O
design -X- _ O
of -X- _ O
synthetic -X- _ O
epitope -X- _ O
mimetics. -X- _ O
The -X- _ O
mimetics -X- _ O
can -X- _ O
be -X- _ O
delivered -X- _ O
to -X- _ O
the -X- _ O
immune -X- _ O
system -X- _ O
in -X- _ O
a -X- _ O
highly -X- _ O
immunogenic -X- _ O
format -X- _ O
on -X- _ O
the -X- _ O
surface -X- _ O
of -X- _ O
synthetic -X- _ O
virus-like -X- _ O
particles. -X- _ O
The -X- _ B-Outcome
scientific -X- _ I-Outcome
challenges -X- _ I-Outcome
in -X- _ I-Outcome
molecular -X- _ I-Outcome
design -X- _ I-Outcome
remain -X- _ I-Outcome
great -X- _ I-Outcome
, -X- _ I-Outcome
but -X- _ I-Outcome
the -X- _ I-Outcome
potential -X- _ I-Outcome
significance -X- _ I-Outcome
of -X- _ I-Outcome
success -X- _ I-Outcome
in -X- _ I-Outcome
this -X- _ I-Outcome
area -X- _ I-Outcome
is -X- _ I-Outcome
even -X- _ I-Outcome
greater. -X- _ I-Outcome
Copyright -X- _ O
© -X- _ O
2013 -X- _ O
European -X- _ O
Peptide -X- _ O
Society -X- _ O
and -X- _ O
John -X- _ O
Wiley -X- _ O
& -X- _ O
Sons -X- _ O
, -X- _ O
Ltd -X- _ O
. -X- _ O

